Reik & Co’s Pfizer PFE Stock Holding History

Reik & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$814K	Hold	28,993	–	–	0.22%	29
2025 Q4	$722K	Sell	28,993 -4,343	-13%	-$110K	0.2%	33
2025 Q3	$849K	Hold	33,336	–	–	0.22%	30
2025 Q2	$808K	Hold	33,336	–	–	0.2%	31
2025 Q1	$845K	Hold	33,336	–	–	0.2%	27
2024 Q4	$883K	Buy	33,336 +7,500	+29%	+$203K	0.21%	27
2024 Q3	$748K	Hold	25,836	–	–	0.18%	31
2024 Q2	$723K	Hold	25,836	–	–	0.19%	32
2024 Q1	$717K	Buy	25,836 +2,000	+8%	+$55.5K	0.18%	31
2023 Q4	$686K	Buy	23,836 +4,176	+21%	+$126K	0.19%	31
2023 Q3	$652K	Buy	19,660 +961	+5%	+$34K	0.19%	30
2023 Q2	$686K	Hold	18,699	–	–	0.19%	35
2023 Q1	$763K	Sell	18,699 -761	-4%	-$32.9K	0.22%	34
2022 Q4	$997K	Hold	19,460	–	–	0.29%	28
2022 Q3	$852K	Hold	19,460	–	–	0.27%	26
2022 Q2	$1.02M	Hold	19,460	–	–	0.29%	27
2022 Q1	$1.01M	Hold	19,460	–	–	0.25%	31
2021 Q4	$1.15M	Hold	19,460	–	–	0.27%	28
2021 Q3	$837K	Hold	19,460	–	–	0.22%	35
2021 Q2	$762K	Hold	19,460	–	–	0.19%	38
2021 Q1	$705K	Hold	19,460	–	–	0.18%	38
2020 Q4	$716K	Sell	19,460 -1,051	-5%	-$38.6K	0.19%	37
2020 Q3	$714K	Hold	20,511	–	–	0.18%	32
2020 Q2	$636K	Buy	20,511 +316	+2%	+$10.7K	0.18%	31
2020 Q1	$625K	Buy	20,195 +280	+1%	+$9.54K	0.2%	27
2019 Q4	$740K	Hold	19,915	–	–	0.19%	30
2019 Q3	$679K	Hold	19,915	–	–	0.18%	32
2019 Q2	$819K	Buy	19,915 +727	+4%	+$28.9K	0.22%	28
2019 Q1	$773K	Hold	19,188	–	–	0.21%	30
2018 Q4	$795K	Hold	19,188	–	–	0.24%	27
2018 Q3	$802K	Hold	19,188	–	–	0.23%	29
2018 Q2	$660K	Sell	19,188 -248	-1%	-$8.47K	0.2%	31
2018 Q1	$654K	Buy	19,436 +1,070	+6%	+$36.8K	0.21%	31
2017 Q4	$631K	Buy	18,366 +2,530	+16%	+$86.3K	0.2%	31
2017 Q3	$536K	Buy	15,836 +1,054	+7%	+$33.9K	0.18%	32
2017 Q2	$471K	Hold	14,782	–	–	0.16%	32
2017 Q1	$480K	Sell	14,782 -106	-0.7%	-$3.34K	0.16%	33
2016 Q4	$459K	Sell	14,888 -3,731	-20%	-$114K	0.16%	36
2016 Q3	$598K	Buy	18,619 +2,804	+18%	+$93.8K	0.21%	32
2016 Q2	$528K	Buy	15,815 +1,475	+10%	+$47.1K	0.18%	34
2016 Q1	$403K	Hold	14,340	–	–	0.15%	40
2015 Q4	$439K	Buy	14,340 +137	+1%	+$4.31K	0.16%	35
2015 Q3	$423K	Hold	14,203	–	–	0.15%	35
2015 Q2	$452K	Hold	14,203	–	–	0.15%	37
2015 Q1	$469K	Buy	14,203 +327	+2%	+$10.4K	0.15%	36
2014 Q4	$410K	Hold	13,876	–	–	0.13%	38
2014 Q3	$389K	Sell	13,876 -6,134	-31%	-$172K	0.13%	39
2014 Q2	$563K	Buy	20,010 +1,370	+7%	+$39.1K	0.19%	36
2014 Q1	$568K	Buy	18,640 +1,897	+11%	+$56.6K	0.2%	31
2013 Q4	$487K	Buy	+16,743	New	+$487K	0.18%	33

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Reik & Co's PFE Position: Q1 2026 in Review

Reik & Co held its Pfizer (PFE) position steady in Q1 2026 at 28,993 shares worth $814K. The position accounts for 0.22% of the portfolio, ranked #29.

Reik & Co first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.15M in Q4 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Reik & Co held 28,993 shares of Pfizer worth $814K as of Q1 2026.
Reik & Co left its Pfizer share count unchanged in Q1 2026.
Pfizer made up 0.22% of Reik & Co's portfolio in Q1 2026, its #29 holding.
Reik & Co first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
Reik & Co's Pfizer position peaked at $1.15M in Q4 2021.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Reik & Co's 13F filing for Q1 2026, filed 5 May 2026.